Aveanna Healthcare Holdings, Inc. (AVAH): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 08:00 ET
- Event date
- 2026-11-13
- Accession no.
- 0001193125-26-459327
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Aveanna discloses Q3 2026 results and 2026 guidance in investor presentation
Aveanna made an investor presentation available on November 13, 2026. It reported Q3 2026 revenue of $695.5 million and Adjusted EBITDA, a non-GAAP measure, of $100.1 million. The presentation included 2026 guidance of revenue >$2.695b and Adjusted EBITDA >$374m.
- Q3 2026 revenue was $695.5 million, up 11.8% from Q3 2025.
- Q3 2026 Adjusted EBITDA was $100.1 million, up 25.0% from Q3 2025.
- 2026 guidance included revenue >$2.695b and Adjusted EBITDA >$374m.
- Reported liquidity was $492.1m, including $197.8m cash on balance sheet.
earningsguidance
Items reported
- Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | avah-20261113.htm |
| EX-99.1 | EX-99.1 | avah-ex99_1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.